Euticals SpA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Euticals SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013315
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Euticals SpA (Euticals) is a chemical company that develops and supplies active pharmaceutical ingredients, fine chemicals and contract manufacturing. The company possess technologies and capabilities in the domains of fermentation and enzymatic chemistry; boronic acids, biaryls, grignards and organolithiums; sterile API, DEA controlled compounds, halogenations and other hazardous chemistries, high potency APIs, heterocycles and oxa acids, among others. It caters to pharmaceuticals, coatings, liquid crystal, metal treatment, fuel cells, agro, cosmetics, oilfield, detergents, and lithography sectors. The company operates in Italy, the US, Germany, and France. Euticals is headquartered in Lodi, Italy.

Euticals SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Euticals SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Euticals SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Euticals SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Euticals SpA, Medical Devices Deals, 2011 to YTD 2017 8
Euticals SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Euticals SpA, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Mandarin Capital Management Completes Sale Of 30% Stake In Euticals 10
Mandarin Capital Partners And Euticals Acquires 35% Stake In Suzhou Tianma Pharma Group Tianji Bio-Pharma 11
Acquisition 12
Albany Molecular Research Acquires Euticals 12
Euticals Acquires Archimica, Fine Chemical Company, From TowerBrook Capital Partners 14
Euticals Acquires 30% Stake in Tianma Tianji Pharma 15
Euticals SpA – Key Competitors 16
Euticals SpA – Key Employees 17
Euticals SpA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Euticals SpA, Pharmaceuticals & Healthcare, Key Facts 2
Euticals SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Euticals SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Euticals SpA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Euticals SpA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Euticals SpA, Medical Devices Deals, 2011 to YTD 2017 8
Euticals SpA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Mandarin Capital Management Completes Sale Of 30% Stake In Euticals 10
Mandarin Capital Partners And Euticals Acquires 35% Stake In Suzhou Tianma Pharma Group Tianji Bio-Pharma 11
Albany Molecular Research Acquires Euticals 12
Euticals Acquires Archimica, Fine Chemical Company, From TowerBrook Capital Partners 14
Euticals Acquires 30% Stake in Tianma Tianji Pharma 15
Euticals SpA, Key Competitors 16
Euticals SpA, Key Employees 17
Euticals SpA, Other Locations 18
Euticals SpA, Subsidiaries 19

★海外企業調査レポート[Euticals SpA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sparton Resources Inc (SRI):企業の財務・戦略的SWOT分析
    Summary Sparton Resources Inc (Sparton Resources) is a diversified company that acquires and develops oil and gas properties in North America and China. The company’s products portfolio includes vanadium, natural gas, crude oil, gold, and vanadium flow batteries, among others. Its energy projects co …
  • De Beers Group Plc:企業の戦略・SWOT・財務情報
    De Beers Group Plc - Strategy, SWOT and Corporate Finance Report Summary De Beers Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • European Bank for Reconstruction and Development:企業のM&A・事業提携・投資動向
    European Bank for Reconstruction and Development - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's European Bank for Reconstruction and Development Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • Milestone Scientific Inc (MLSS):医療機器:M&Aディール及び事業提携情報
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments in the medical and dental fields. The company’s medical specialties include anesthesiology, orthopedic surgery, pain medicine, …
  • Intermountain Healthcare Inc-医療機器分野:企業M&A・提携分析
    Summary Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, …
  • TimberWest Forest Corporation:企業の戦略・SWOT・財務情報
    TimberWest Forest Corporation - Strategy, SWOT and Corporate Finance Report Summary TimberWest Forest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cognition Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics. The company uses its proprietary biology and chemistry platforms for the development of novel drug targets and disease modifying therapies for the treatment …
  • Mattel, Inc.:企業の戦略・SWOT・財務情報
    Mattel, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mattel, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • MetLife, Inc.:企業の戦略・SWOT・財務情報
    MetLife, Inc. - Strategy, SWOT and Corporate Finance Report Summary MetLife, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Flowserve Corp (FLS):企業の財務・戦略的SWOT分析
    Flowserve Corp (FLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • National Shipping Company of Saudi Arabia (4030):石油・ガス:M&Aディール及び事業提携情報
    Summary National Shipping Company of Saudi Arabia (Bahri) is a joint stock shipping company, which purchases, charters and operates shipping vessels for the transportation of crude oil, liquefied petroleum gas (LPG), petrochemicals, general cargo, passengers and dry bulk. It operates a fleet of very …
  • OBJ Ltd (OBJ)-医療機器分野:企業M&A・提携分析
    Summary OBJ Ltd (OBJ) is a developer of magnetic micro-array drug and ingredient delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and pre-commer …
  • Chevron Corp (CVX):企業の財務・戦略的SWOT分析
    Chevron Corp (CVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Major Drilling Group International Inc (MDI):企業の財務・戦略的SWOT分析
    Major Drilling Group International Inc (MDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Hemispherx Biopharma Inc (HEB):製薬・医療:M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …
  • Bemis Company Inc (BMS):企業の財務・戦略的SWOT分析
    Bemis Company Inc (BMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Teijin Limited:企業の戦略・SWOT・財務情報
    Teijin Limited - Strategy, SWOT and Corporate Finance Report Summary Teijin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • AccentCare Inc:企業の戦略的SWOT分析
    AccentCare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Medytox Inc (086900):企業の財務・戦略的SWOT分析
    Summary Medytox Inc (Medytox) develops, manufactures and markets biopharmaceutical products. Its products include botulinum toxin type A product, hyaluronic acid filler, medical devices, prescription cream, toxin detection kits and antitoxin therapeutics for treating skin disorders. The company is a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆